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PREVIOUS STUDIES in liver transplant patients indicate an increase in the 
trough cyclosporine (CsA) concentrations 
subsequent to the removal or clamping of the 
T tube. I•2 Since less than 1 % of an adminis-
tered dose of CsA is excreted as the 
unchanged drug, enterohepatic recirculation 
is not responsible for such an observation.3 It 
is likely that improved bile flow into the gut 
secondary to the clamping process increases 
CsA absorption and therefore the trough con-
centrations. Our objective was to determine 
the role of bile and bile salts on the absorption 
of CsA in dogs. 
METHODS 
Five male beagle dogs weighing approximately 15 kg 
were used in this four-phase study. During each phase of 
the study the dogs were fasted overnight. and food was 
withheld for a period of seven hours after drug adminis-
tration. Water was allowed ad libitum. On day 1 of the 
study (phase 1) the dogs received CsA (20 mg/kg) orally. 
On day 8 (phase 2) the same groups of dogs received 1 g 
lecithin and 250 mg chenodeoxycholic acid (CCA) as a 
suspension in water 15 minutes prior to oral CsA (20 mg/ 
kg). On day 9 the dogs underwent surgery (choledocho-
ureterostomy with a right nephrectomy) to divert bile 
from the gut. On day 29 (phase 3) these dogs received an 
oral dose of CsA (20 mg/kg). On day 49 (phase 4) 1 g of 
lecithin and 250 mg CCA were administered 15 minutes 
prior to the CsA dose (20 mg/kg). During each phase 
blood samples were obtained at 0,1,2,3,4,6,8,10,12, 
16, and 24 hours after drug administration and analyzed 
for unchanged CsA by a high-performance liquid chro-
From the Schools of Medicine and Pharmacy. Univer-
sity of Pittsburgh. 
Supported by a grant from Sandoz Pharmaceuticals, 
East Hanover. NJ and Children's Liver Foundation, 
Maplewood. NJ. 
Address reprint requests 10 R. Venkataramanan. PhD. 
Clinical Pharmacokinetics Laboratory. 807 Salk Hall. 
University of Pittsburgh. Pittsburgh. P A 15261. 
© 1987 by Grune & Stratton. Inc. 
0041-1345/87//901-445$03.00/0 
matographic method as described earlier.4 Liver function 
tests were monitored in all the animals during the COurse 
of study. Pharmacokinetic parameters were calculated 
according to standard procedures. 
RESULTS 
The liver function tests were normal in all 
the dogs during the study period. Oral absorp-
tion of CsA was rapid'in all the animals, with 
peak blood concentrations being reached with 
in two hours. Subsequent to the administra-
tion of lecithin and CCA, peak blood levels 
were observed within one hour. The mean 
(±SD) maximum blood concentration (Cma.) 
of CSA (1,165 ± 280 ng/mL) was signifi-
cantly higher in phase 2 as compared with 
phase 1. The mean area under the blood 
concentration time curve (AUCo) in phase 2 
was 46% greater than the AUCo during phase 
1. 
There was a significant decrease (P < .05) 
in the mean Cm .. (76%)'and the AUC (75%) 
following bile diversion. The mean (±SD) 
AUC in phase 3 was 1,888 (±732) as com-
pared with 7,429 (±2,032) ng . min/mL -I in 
phase 1. The mean AUC of 3,744 (± 1,405) 
ng . min/mL -I during phase 4 was signifi-
cantly higher than the mean AUC of 1,888 
(± 732) ng . min/mL -I during phase 3. How-
ever, the Cm .. and time for peak blood concen-
trations were not significantly different 
between phase 3 and 4. 
DISCUSSION 
Lipids and lipid-soluble compounds require 
bile and bile salts for absorption. Since CsA is 
a highly lipid soluble compound one would 
anticipate a potential role for bile on the 
absorption of CsA. In liver transplant 
patients, we have observed significant 
increases in the blood esA concentration over 
a dosing interval following T tube ciamping.2 
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ROLE OF BILE IN CYCLOSPORINE ABSORPTION 
Since very little unchanged CsA is excreted in 
the bile, enterohepatic recirculation cannot 
account for this observation. 
In this study we have documented that bile 
and a bile salt are essential for CsA absorption 
in dogs. Biliary diversion resulted in a signifi-
cant impairment in the absorption of CsA. 
Coadministration of bile salts improved the 
absorption of CsA in normal dogs and signifi-
cantly increased its absorption in bile-
depleted dogs. The rate of absorption of CsA 
as indicated by the time taken to achieve 
maximal blood concentration was also signifi-
cantly increased by the administration of 
CCA to normal dogs. 
The poor bioavailability of CsA observed in 
the liver transplant patients during the imme-
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diate postoperative periods and in liver disease 
patientsS is presumably related to the lack of 
sufficient bile and bile salts for facilitation of 
CsA absorption. Coadministration of CsA 
with bile salts should be considered in patients 
as a possible way to increase CsA absorption. 
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